174 related articles for article (PubMed ID: 35427485)
1. Genome-wide screening for genes involved in the epigenetic basis of fragile X syndrome.
Vershkov D; Yilmaz A; Yanuka O; Nielsen AL; Benvenisty N
Stem Cell Reports; 2022 May; 17(5):1048-1058. PubMed ID: 35427485
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
[TBL] [Abstract][Full Text] [Related]
4. DNA Methylation, Mechanisms of
Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
[TBL] [Abstract][Full Text] [Related]
5. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
[TBL] [Abstract][Full Text] [Related]
6. Human pluripotent stem cell models of Fragile X syndrome.
Bhattacharyya A; Zhao X
Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
[TBL] [Abstract][Full Text] [Related]
7. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics of fragile X syndrome and fragile X-related disorders.
Kraan CM; Godler DE; Amor DJ
Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
[TBL] [Abstract][Full Text] [Related]
10. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
[TBL] [Abstract][Full Text] [Related]
11. Role of CTCF protein in regulating FMR1 locus transcription.
Lanni S; Goracci M; Borrelli L; Mancano G; Chiurazzi P; Moscato U; Ferrè F; Helmer-Citterich M; Tabolacci E; Neri G
PLoS Genet; 2013; 9(7):e1003601. PubMed ID: 23874213
[TBL] [Abstract][Full Text] [Related]
12. FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells.
Avitzour M; Mor-Shaked H; Yanovsky-Dagan S; Aharoni S; Altarescu G; Renbaum P; Eldar-Geva T; Schonberger O; Levy-Lahad E; Epsztejn-Litman S; Eiges R
Stem Cell Reports; 2014 Nov; 3(5):699-706. PubMed ID: 25418717
[TBL] [Abstract][Full Text] [Related]
13. Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation.
Tabolacci E; Pomponi MG; Remondini L; Pietrobono R; Nobile V; Pennacchio G; Gurrieri F; Neri G; Genuardi M; Chiurazzi P
Eur J Hum Genet; 2020 May; 28(5):567-575. PubMed ID: 31804632
[TBL] [Abstract][Full Text] [Related]
14. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B
Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411
[TBL] [Abstract][Full Text] [Related]
16. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus.
Alisch RS; Wang T; Chopra P; Visootsak J; Conneely KN; Warren ST
BMC Med Genet; 2013 Jan; 14():18. PubMed ID: 23356558
[TBL] [Abstract][Full Text] [Related]
18. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
19. Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated
Kumari D; Sciascia N; Usdin K
Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32230785
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
Gerhardt J
Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
